Incidence and Burden of Respiratory Syncytial Virus-Associated Hospitalizations Among People 65 and Older in France: A National Hospital Database Study - Takeaways - MDSpire

Incidence and Burden of Respiratory Syncytial Virus-Associated Hospitalizations Among People 65 and Older in France: A National Hospital Database Study

  • By

  • Stéphane Marot

  • Clarisse Demont

  • Théophile Cocherie

  • Miao Jiang

  • Charlotte Charpentier

  • Andre Araujo

  • Tianyi Lu

  • Mathieu Uhart

  • Nadia El Mouaddin

  • Magali Lemaitre

  • Sophie Larrieu

  • Clélia Bignon-Favary

  • Emilie Lambourg

  • Arnaud Cheret

  • David Martin

  • Anne-Geneviève Marcelin

  • Diane Descamps

  • Vincent Calvez

  • Quentin Le Hingrat

  • September 15, 2025

  • 0 min

Share

  • 1

    RSV poses a significant health threat to older adults, particularly those with chronic conditions, leading to severe respiratory infections and high mortality.

  • 2

    Hospitalization rates for RSV in adults aged 75+ range from 85 to 221 per 100,000, with inpatient mortality rates between 8.9% and 10.4%.

  • 3

    High-risk adults aged 65–74 experience even higher adjusted incidence rates of RSV hospitalizations, ranging from 161 to 735 per 100,000.

  • 4

    The economic burden of RSV hospitalizations in France for older adults is substantial, with annual costs estimated between €27 and €76 million.

  • 5

    Improved diagnostics and targeted vaccination programs are crucial to reduce the underreported impact of RSV on vulnerable elderly populations.

Original Source(s)

Incidence and Burden of Respiratory Syncytial Virus-Associated Hospitalizations Among People 65 and Older in France: A National Hospital Database Study

  • by Stéphane Marot, Clarisse Demont, Théophile Cocherie, Miao Jiang, Charlotte Charpentier, Andre Araujo, Tianyi Lu, Mathieu Uhart, Nadia El Mouaddin, Magali Lemaitre, Sophie Larrieu, Clélia Bignon-Favary, Emilie Lambourg, Arnaud Cheret, David Martin, Anne-Geneviève Marcelin, Diane Descamps, Vincent Calvez, Quentin Le Hingrat

  • September 15, 2025

Related Content

Senate Report Details Early Myocarditis Signals After COVID-19 Vaccination

Investigative report cites internal communications, VAERS data, and CDC case reviews describing myocarditis and pericarditis reports in adolescents and young adults after mRNA COVID-19 vaccination.

RFK Jr. Takes Health Agenda on the Road

Touring Ohio, RFK Jr. highlights food quality and recovery services while steering attention away from vaccine controversies.

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization